Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Urinary Tract Infection, January 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 335 articles: HTML format

Single Articles

1. SALIH TS, Al-Rrassam ZT, Muhammad MA, Ziwar HR, et al
   Genome sequence data of multidrug-resistant Enterococcus faecalis HMTZ24 carrying multiple virulence factors, isolated from a urinary tract infection in Mosul, Iraq.
   Data Brief. 2025;64:112352.
   Abstract
   
   
2. PANDEY S, Aravaanan ASK, Bhaskar E, Silambanan S, et al
   Biomarkers innovation in urinary tract infections: Insights into pathophysiology, antibiotic resistance, and clinical applications.
   World J Nephrol. 2025;14:110749.
   Abstract
   
   
3. MAY SS, Veillette JJ, Butler AM, Olson J, et al
   Effect of oral beta-lactam dosing on outcomes of bacteremic Gram-negative urinary tract infections: a real-world analysis.
   Microbiol Spectr. 2025 Dec 31:e0170425. doi: 10.1128/spectrum.01704.
   Abstract
   
   
4. WAWRYSIUK SP, Bogusiewicz M, Pachcinski O, Grywalska E, et al
   Fosfomycin susceptibility of uropathogens resistant to antibiotics used in peri-operative prophylaxis of urinary tract infection among patients after urogynaecological surgery.
   Ann Agric Environ Med. 2025;32:488-491.
   Abstract
   
   
5. MIR SS, Ali E, Alghamdi SAA, Alghamdi NM, et al
   Antimicrobial Resistance in Urinary Tract Infections Among Patients with and Without Renal Comorbidities: A Retrospective Study from Al-Baha, Saudi Arabia.
   Pathogens. 2025;14:1297.
   Abstract
   
   
6. KHALID F, Aljohani WJ, Akram A, Bukhari A, et al
   Epidemiology and Antimicrobial Resistance of Uropathogens in a Tertiary Care Center in Riyadh, Saudi Arabia: A One-Year Retrospective Analysis.
   Pathogens. 2025;14:1254.
   Abstract
   
   
7. TODI S, Soman R, Mehta Y, Ramasubramanian V, et al
   Plazomicin in multidrug-resistant complicated urinary tract infections: a scoping review.
   Ther Adv Infect Dis. 2025;12:20499361251401104.
   Abstract
   
   
8. SINGH B, Patel A, Agrawal RP, Jain SK, et al
   Trends in antibiotics resistance for urinary tract infections - A five-year retrospective study in India.
   Bioinformation. 2025;21:3010-3013.
   Abstract
   
   
9. DRAKUL D, Joksimovic B, Pejcic AV, Zivkovic-Zaric R, et al
   Rising Prevalence of Multidrug-Resistant Klebsiella spp. in Urinary Tract Infections: A Study from Doboj Hospital.
   Antibiotics (Basel). 2025;14:1234.
   Abstract
   
   
10. BENEA A, Stelea L, Turaiche M, Bogdan I, et al
    REACT-UTI: A 72-Hour Composite to Predict Early Non-Response and Length of Stay in Hospitalized Adults with Lower Urinary Tract Infection-A Prospective Observational Study.
    Biomedicines. 2025;13:2870.
    Abstract
    
    
11. SINGH P, Ahmed MN, Thakur AK, Srivastava AK, et al
    Epidemiological and antimicrobial resistance profile of catheter-associated and non-catheter urinary tract infections in trauma patients (2017-2024).
    BMC Infect Dis. 2025;25:1810.
    Abstract
    
    
12. RANGRAZ JEDDI F, Nabovati E, Sharif R, Sharif AS, et al
    The effects of information technology interventions for optimizing antibiotic prescribing in urinary tract infections: a systematic review.
    BMC Infect Dis. 2025;25:1752.
    Abstract
    
    
13. BROUGHTON E, Colosia A, Bektas M, Kuper K, et al
    Assessing the economic burden of complicated urinary tract infection: A systematic literature review.
    Eur J Health Econ. 2025 Dec 29. doi: 10.1007/s10198-025-01846.
    Abstract
    
    
14. WU KC, Belza B, Berry DL, Lewis FM, et al
    Digital Health Interventions for Urinary Tract Infection Prevention and Management in People Living with Dementia and Their Family Caregivers: A Scoping Review.
    Gerontologist. 2025 Dec 29:gnaf268. doi: 10.1093.
    Abstract
    
    
15. VANDERPOORTEN L, Vandevelde S, De Corte L, Holvoet J, et al
    Overview and resistance profiles of isolated pathogens in women with uncomplicated urinary tract infection in primary care.
    Acta Clin Belg. 2025 Dec 29:1-9. doi: 10.1080/17843286.2025.2596150.
    Abstract
    
    
16. GECKALAN D, Simsek OO, Cil Z
    Diagnostic Utility of High-Sensitivity C-Reactive Protein and Inflammatory Biomarkers in Pediatric Atypical Urinary Tract Infections.
    Niger J Clin Pract. 2025;28:1464-1469.
    Abstract
    
    
17. ARAYA T, Kita T, Higashi T, Hara R, et al
    Hyperammonemic Encephalopathy Caused by Obstructive Urinary Tract Infection Due to Urease-Positive Corynebacterium riegelii in an Elderly Woman: A Case Report.
    Cureus. 2025;17:e97833.
    Abstract
    
    
18. SADAKA Y, Nakajima K, Sasaki Y, Tsurugaya M, et al
    Preliminary clinical evaluation of cefmetazole dosing regimens in Japanese patients with urinary tract infections.
    J Pharm Health Care Sci. 2025 Dec 27. doi: 10.1186/s40780-025-00535.
    Abstract
    
    
19. KIBWANA UO, Manyahi J, Sabas DM, Chande R, et al
    Ciprofloxacin resistance in community and hospital-acquired urinary tract infections: a systematic review and meta-analysis from African population.
    BMC Infect Dis. 2025 Dec 28. doi: 10.1186/s12879-025-11546.
    Abstract
    
    
20. FLOREZ-NAVAS PC, Josa D, Silva-Monsalve E, Ballesteros N, et al
    Infective endocarditis caused by Escherichia coli O25b:H4-B2-ST131: A case report providing genotypic, phenotypic, and phylogenetic insights.
    J Int Med Res. 2025;53:3000605251404825.
    Abstract
    
    
21. RODER J, Wingen-Heimann SM, Seidel D, Froitzheim AC, et al
    Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective.
    Infection. 2025 Dec 26. doi: 10.1007/s15010-025-02711.
    Abstract
    
    
22. ISHAQ Z, Khalil K, Faiz F, Haider U, et al
    Genomic characterization and comparative analysis of multidrug-resistant uropathogenic Escherichia coli strain U1 from Pakistan revealed ST131 as dominant clade.
    Antonie Van Leeuwenhoek. 2025;119:22.
    Abstract
    
    
23. GAO K, Kumar V, Divinagracia G, Kirn TJ, et al
    Use of BacterioScan 216Dx to reduce antibiotic use for suspected urinary tract infection in the emergency department.
    Antimicrob Steward Healthc Epidemiol. 2025;5:e322.
    Abstract
    
    
24. MADARAS-KELLY KJ, Nakasone T, Maghari S, Taylor J, et al
    A pilot intervention to improve the management of urinary tract infections in outpatient settings.
    Antimicrob Steward Healthc Epidemiol. 2025;5:e338.
    Abstract
    
    
25. AUDENET F, Panis A, Fraisse G, Dariane C, et al
    Early Stent Removal at Bedside Decreases Urinary Tract Infection in Kidney Transplant Recipients: A Monocentric Prospective Study.
    Transpl Infect Dis. 2025 Dec 24:e70148. doi: 10.1111/tid.70148.
    Abstract
    
    
26. MAYOMBO NGOUSSOU E, Mounioko F, Mundunge M, Mabika Mabika R, et al
    Descriptive Epidemiology of Klebsiella spp. Urinary Tract Infections in Central Africa.
    Biomed Res Int. 2025;2025:9558259.
    Abstract
    
    
27. YE LZ, Sun JX, Chen J, Cen KK, et al
    Machine learning model for predicting urinary tract infection risk in febrile children under 3 years of age.
    Front Pediatr. 2025;13:1677292.
    Abstract
    
    
28. DIAO P, Zhong S, Chen D, Wang H, et al
    Construction and Evaluation of Nomogram Prediction Model for Urinary Tract Infection After Transurethral Bipolar Plasmakinetic Prostatectomy.
    Risk Manag Healthc Policy. 2025;18:3901-3910.
    Abstract
    
    
29. REED AL, Kayuni SA, Musaya J, Stothard JR, et al
    Development of a dynamical model to enhance understanding of epidemiology of schistosomiasis in school-aged-children.
    Sci Rep. 2025;15:45091.
    Abstract
    
    
30. FENG Q, He W, Xu Q, Cheng W, et al
    Analysis of risk factors for urinary tract infections caused by extended spectrum beta-Lactamases-producing Escherichia coli and establish the nomogram model.
    Urolithiasis. 2025;54:7.
    Abstract
    
    
31. VEIGAS E, Lanca Pereira J, Oliveira N, Lopes A, et al
    When the Urine Turns Purple: Not Always a Urinary Tract Infection.
    Cureus. 2025;17:e97200.
    Abstract
    
    
32. HILL JB, Simons A, Wright G, Anderson KE, et al
    Impact of recently initiated medications on the incidence of urinary tract infections in patients with type 2 diabetes: an observational case-control study.
    Ther Adv Drug Saf. 2025;16:20420986251401515.
    Abstract
    
    
33. DABABNEH A, Sanyaolu LN, Ahmed H, Alagiyawanna D, et al
    Women's experiences of the assessment and management of urinary tract infections during the COVID-19 pandemic: a qualitative analysis of free-text comments from a national survey in England.
    JAC Antimicrob Resist. 2025;7:dlaf241.
    Abstract
    
    
34. KUANG Y, Ni W, Wu J, Qin J, et al
    Boosting Array-based Diagnosis of Urinary Tract Infections via a Heterobifunctional Bridge-Driven Strategy.
    Angew Chem Int Ed Engl. 2025 Dec 21:e23348. doi: 10.1002/anie.202523348.
    Abstract
    
    
35. WANG X, Yin L, Li H, Li H, et al
    Orthogonal Biochemical Sensing for Concentration-Independent Bacterial Fingerprinting.
    Anal Chem. 2025;97:27844-27853.
    Abstract
    
    
36. LUKASIAK A, Wesolowski W, Neumann J, Lewandowska N, et al
    Groundwork for phage therapy: multi-faceted comparative analysis of lytic bacteriophages infecting uropathogenic Escherichia coli.
    Virology. 2026;615:110738.
    Abstract
    
    
37. KO CC, Chang LC, Hung KC, Lai YC, et al
    Association Between Sugammadex Use and Risk of Postoperative Urinary Complications after Metabolic and Bariatric Surgery: A Multi-Institutional Study.
    Obes Surg. 2025;35:5092-5100.
    Abstract
    
    
38. ZHANG EZ, Millot JC, Balasubramanian A, Davis L, et al
    Persistent Sex Disparities in Bladder Cancer Diagnosis, an Analysis of National Trends from 2012 to 2021.
    Urol Pract. 2025 Oct 10:101097UPJ0000000000000904.
    Abstract
    
    
39. HAMDAN D, Adcock JT
    Nontyphoidal Salmonella as a Rare Cause of UTI: A Case Report, Systematic Review, and Analysis of Surveillance Data.
    Int Urogynecol J. 2025;36:2349-2362.
    Abstract
    
    
40. MORAGAS A, Monfa R, Garcia-Sangenis A, Llor C, et al
    Accuracy of leukocyte esterase and nitrite tests for diagnosing bacteriuria in older adults: a systematic review and meta-analysis.
    Clin Microbiol Infect. 2026;32:19-29.
    Abstract
    
    
41. NIETO-VEGA FA, Rodriguez-Azor B, Martinez-Rivera V, Reina-Gonzalez AM, et al
    Primary vesicoureteral reflux presenting as hypertensive crisis and thrombotic microangiopathy.
    Hipertens Riesgo Vasc. 2025;42:302-304.
    Abstract
    
    
42. DOUGLASS KM, Laus K, DeAndrade S, Whitaker T, et al
    Evaluation of the Safety of Virtual Visits After In-Clinic Botox(R) Injection: A Quality Improvement Study.
    Int Urogynecol J. 2025;36:2427-2434.
    Abstract
    
    
43. WOLTSCHE J, Pacher-Deutsch C, Furst S, Gulden L, et al
    Microbial Dysbiosis in the Urinary Microbiome of Patients with Cirrhosis.
    Am J Gastroenterol. 2025 Jul 7. doi: 10.14309/ajg.0000000000003634.
    Abstract
    
    
44. PILLAI NR, Hulkower A, Gallagher S, Abraham C, et al
    Consultation-Liaison Case Conference: Treatment Over Objection in the General Hospital.
    J Acad Consult Liaison Psychiatry. 2025;66:546-552.
    Abstract
    
    
45. KOLANKO MA, Jackson R, Soreq E, David MC, et al
    Biomarkers.
    Alzheimers Dement. 2025;21 Suppl 2:e106435.
    Abstract
    
    
46. RUTA F, Avram C, Mardale E, Maior R, et al
    Histamine-Producing Intestinal Dysbiosis and Its Role in Lower Urinary Tract Infections and Irritable Bowel Syndrome in Young Women.
    Nutrients. 2025;18:16.
    Abstract
    
    
47. LIAO Y, Li Y, Wang X, Pu F, et al
    Comparative study between female patients with functional dyspepsia accompanied by abnormal urinalysis and those with urinary tract infections: a retrospective case-control study.
    Sci Rep. 2026 Jan 9. doi: 10.1038/s41598-026-35609.
    Abstract
    
    
48. ARAYA ORELLANA J, Basoalto Leon J, Napoletani Ramirez R, Aran-Sekul T, et al
    Identification and susceptibility profile of microorganisms isolated directly from urine in a cross-sectional study using matrix-assisted laser desorption/ionization time-of-flight and Phoenix M50.
    Medwave. 2026;26:e3049.
    Abstract
    
    
49. YANG J, Du M, Duan Z, Cai M, et al
    Epidemiological characteristics and antibiotic resistance of pathogens in urinary tract infection in Chengdu 2019-2023, China.
    BMC Microbiol. 2026 Jan 8. doi: 10.1186/s12866-026-04719.
    Abstract
    
    
50. ISMAIL ZS, Zhao T, Liang SH, Chibale K, et al
    Blujepa for the treatment of uncomplicated urinary tract infections.
    Trends Pharmacol Sci. 2026 Jan 7:S0165-6147(25)00283.
    Abstract
    
    
51. LOPEZ PEREZ E, Garcia-Astillero Vallecillo V, Gomez de Vicente JM, Bravo Marin S, et al
    MANCOIT Study: Pilot study on the prevention of recurrent postcoital urinary tract infection in women with D-mannose plus proanthocyanidins (PAC).
    Actas Urol Esp (Engl Ed). 2026 Jan 5:501911. doi: 10.1016/j.acuroe.2026.501911.
    Abstract
    
    
52. LIBO E, Weiss T, Youngster I, Adler A, et al
    Pathogen distribution and antimicrobial resistance in simple and complicated urinary tract infections in pediatric patients.
    Infection. 2026 Jan 7. doi: 10.1007/s15010-025-02704.
    Abstract
    
    
53. GAJDA M, Kapturkiewicz C, Kapusta D, Hareza D, et al
    Applying international urinary tract infection guidelines in Poland: epidemiologic insights from Southern Poland.
    Pol Arch Intern Med. 2026 Jan 7:17193. doi: 10.20452/pamw.17193.
    Abstract
    
    
54. HOSSAIN A, Hossain SA, Fatema AN, Wahab A, et al
    Retraction notice to "Age and gender-specific antibiotic resistance patterns among Bangladeshi patients with urinary tract infection caused by Escherichia coli" [Heliyon 6 (2020) e04161].
    Heliyon. 2025;11:e44254.
    Abstract
    
    
55. LU CY, Liu Q, Feng P, Liu HY, et al
    The Role of Prognostic Nutritional Index in UTI Susceptibility Among Female Type 2 Diabetic Patients.
    J Diabetes Res. 2025;2025:6890754.
    Abstract
    
    
56. XUE Z, Chen H, Qi Y, Zeng Q, et al
    Mechanistic insights into the inhibitory effect of epigallocatechin gallate on the production of virulence factors in Proteus mirabilis.
    Medicine (Baltimore). 2026;105:e46893.
    Abstract
    
    
57. CHANG Z, Chen J, Wang Z, Liang Y, et al
    Rapid and accurate preoperative diagnosis of urinary tract infections in urolithiasis patients: clinical validation of the HB&L system.
    BMC Infect Dis. 2026 Jan 6. doi: 10.1186/s12879-025-12444.
    Abstract
    
    
58. ADDO HO, Barimah AJ, Usman AS, Kuu-Arah P, et al
    Utilisation of antibiotics in the management of urinary tract infections among women of reproductive age at a district hospital in Ghana.
    Sci Rep. 2026 Jan 7. doi: 10.1038/s41598-025-33884.
    Abstract
    
    
59. HAMILTON ADK, Hornhaver J, Sparsoe LV, Sorensen MV, et al
    Oral Acid Load Lowers Bacterial Burden and Elevates Urinary Proinflammatory Response in a Mouse Model of Urinary Tract Infection.
    Acta Physiol (Oxf). 2026;242:e70149.
    Abstract
    
    
60. LI Y, Chen X, Chen D
    Nursing Management for the Prevention of Urinary Catheter-Associated Urinary Tract Infections in the Emergency Intensive Care Unit: A Retrospective Study.
    Arch Esp Urol. 2025;78:1410-1417.
    Abstract
    
    
61. ABOLANLE P, Akintelure D, Eylert M, Wijayasuriya DS, et al
    Exploring the Efficacy of Methenamine Hippurate Across Different Patient Groups With Recurrent Urinary Tract Infections: Experience From a University Teaching Hospital in South Wales, United Kingdom.
    Cureus. 2025;17:e98511.
    Abstract
    
    
62. CHAMODINI K, Samarasingha S, Didulanga K, Jayasekara C, et al
    Bioactive Compounds in Natural Remedies and Functional Foods for Managing Recurrent Urinary Tract Infections in Postmenopausal Women.
    J Menopausal Med. 2025;31:145-157.
    Abstract
    
    
63. BITSORI M, Poulaki RI, Galanakis E
    Diagnosis of urinary tract infections in the pediatric population - current practices, advances and progress.
    Expert Rev Anti Infect Ther. 2026 Jan 5:1-14. doi: 10.1080/14787210.2025.2611304
    Abstract
    
    
64. DUFF P
    Infection after cesarean delivery: diagnosis, pathophysiology, management, and prevention.
    Am J Obstet Gynecol. 2026;233.
    Abstract
    
    
65. FERNANDEZ-RUIZ M, San-Juan R, Montero MM, Pano-Pardo JR, et al
    How can we optimize the diagnostic and therapeutic approach of urinary tract infection? Expert opinion-based recommendations.
    Enferm Infecc Microbiol Clin (Engl Ed). 2026 Jan 2:503027.
    Abstract
    
    
66. POLYZOU E, Tsoupra S, Gavatha M, Skintzi K, et al
    Bacteremic versus Non-Bacteremic Urinary Tract Infections: Predictors of Poor Clinical Outcome.
    Rom J Intern Med. 2026 Jan 3. doi: 10.2478/rjim-2025-0025.
    Abstract
    
    
67. SINGLEY CM, Kurumaddali A, Hoover JL
    Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model.
    Antimicrob Agents Chemother. 2026;70:e0117625.
    Abstract
    
    
68. BELLANKIMATH AB, Branders S, Kegel I, Ali J, et al
    Metagenomic sequencing enables accurate pathogen and antimicrobial susceptibility profiling in complicated UTIs in approximately four hours.
    Nat Commun. 2025;17:187.
    Abstract
    
    
69. CICEK M, Tufekci B, Fehruzlu E, Kose M, et al
    Annual changes of antimicrobial resistance and antibiotic preference in urology inpatient group; a tertiary hospital experience.
    BMC Urol. 2025;26:3.
    Abstract
    
    
70. CHAKULYA M, Chisompola D, Chawela N, Hatwiko H, et al
    Prevalence and associated factors of schistosomiasis among children and adolescents visiting Chitokoloki Mission Hospital of Zambezi District.
    BMC Infect Dis. 2025;26:11.
    Abstract
    
    
71. BONTEMPS-GALLO S
    The cost of chronicity: Pseudomonas aeruginosa's silent evolution in the urinary tract.
    Microbiol Spectr. 2026;14:e0338125.
    Abstract
    
    
72. SUGIYAMA Y, Nakamura A, Ohta H, Fujita T, et al
    PstSCAB and SapBCDF are putrescine exporters in Proteus mirabilis.
    Microbiol Spectr. 2026;14:e0430623.
    Abstract
    
    
73. RAUSCHE P, Kutz JM, Rakotomalala Z, Randrianasolo BS, et al
    Evaluation of Midwife-Led Colposcopy for Female Genital Schistosomiasis Screening at Primary Level of Care in Rural Madagascar: A Cross-Sectional Study.
    Trop Med Int Health. 2025 Oct 30. doi: 10.1111/tmi.70049.
    Abstract
    
    
74. OZAY Y, Sever M, Yesilaras M, Unal A, et al
    The usefulness of previous urine culture and antibiogram results in guiding empiric antibiotic selection in the emergency department.
    Ir J Med Sci. 2025;194:2475-2483.
    Abstract
    
    
75. ALREDHA RDA, Haddawi KH, Alzerfi HSR
    Beyond the bladder: Escherichia coli UTIs drive systemic inflammation and RANKL-mediated bone resorption.
    Ir J Med Sci. 2025;194:2319-2327.
    Abstract
    
    
76. UNHAPIPATPONG C, Wang C, Schwenger KJP, Zirabamuzaale J, et al
    Association between mixed oil lipid emulsions and all-cause infections relative to soybean oil lipid emulsions in hospitalized adults: A retrospective cohort study.
    JPEN J Parenter Enteral Nutr. 2026;50:78-87.
    Abstract
    
    
77. PRAKASH A, Besra SK, Ansari MH, Ali M, et al
    A Prospective Analysis of Neurosurgery Intensive Care Unit Infections - A Tertiary Center Study.
    Ann Afr Med. 2026;25:34-37.
    Abstract
    
    
78. KHALIL I, Sayed A, Kabir AKMA, Alam MN, et al
    Determinants of multidrug-resistant urinary tract infections: A retrospective cross-sectional study from a tertiary care hospital in southern Bangladesh.
    PLOS Glob Public Health. 2026;6:e0005022.
    Abstract
    
    
79. WALL KM, Vwalika B, Secor WE, Vazquez EG, et al
    Imported female genital schistosomiasis: a neglected health issue across borders.
    J Glob Health. 2026;16:03002.
    Abstract
    
    
80. MENDES J, Jaiswal S, Ibrahim S, Abdelsalam D, et al
    Urinary Tract Infection Masquerading as a Neuromyelitis Optica Spectrum Disorder Exacerbation: A Case Report.
    Case Rep Ophthalmol. 2025;17:47-51.
    Abstract
    
    
81. GORDON D, Skountrianos G, Newman DK, Simmons J, et al
    Intermittent Catheters With Integrated Features Designed to Reduce the Risk of Urinary Tract Infection: Findings From the Continence Care Registry, a Multinational, Observational, Longitudinal Study.
    J Wound Ostomy Continence Nurs. 2026;53:40-46.
    Abstract
    
    
82. WONDIMKUN YA, Inacio MC, Bennett N, Worth LJ, et al
    Incidence and Factors Associated With Hospitalizations for Urinary Tract Infections Among Older People Residing in Long-Term Care Facilities.
    J Am Med Dir Assoc. 2026 Jan 12:106073. doi: 10.1016/j.jamda.2025.106073.
    Abstract
    
    
83. MUSAYA J, Kayuni SA, Kapira D, Archer J, et al
    Public health challenge of hybridization in urogenital schistosomiasis: New insights and one health perspectives from Malawi.
    Philos Trans R Soc Lond B Biol Sci. 2026;381:20240518.
    Abstract
    
    
84. O'FERRALL AM, Cunningham LJ, Lally D, Makaula P, et al
    Dynamic interactions between Schistosoma haematobium, Schistosoma mattheei and Schistosoma mansoni underscore the complex polyparasitism of intestinal schistosomiasis in southern Malawi.
    Philos Trans R Soc Lond B Biol Sci. 2026;381:20250191.
    Abstract
    
    
85. KAYUNI SA, Kinley L, Mainga B, Kumwenda D, et al
    Clinical morbidity of single or mixed schistosome species infection in two communities of southern Malawi.
    Philos Trans R Soc Lond B Biol Sci. 2026;381:20240524.
    Abstract
    
    
86. RAFFERTY H, Bustinduy A
    Finding hybrid schistosomes in genital schistosomiasis: are we missing their clinical relevance?
    Philos Trans R Soc Lond B Biol Sci. 2026;381:20250086.
    Abstract
    
    
87. CUNNINGHAM LJ, Nkolokosa C, Risse M, Makaula P, et al
    Tracking the spatial and longitudinal dynamics of mixed infections of urogenital and intestinal schistosomiasis, inclusive of Schistosoma mattheei, in two sentinel rural communities from southern Malawi.
    Philos Trans R Soc Lond B Biol Sci. 2026;381:20240520.
    Abstract
    
    
88. KRASOVSKA B, Staravoitova K, Loginova V, Leonenko K, et al
    Persistent Urinary Tract Infection Despite Targeted Antibiotics: The Role Of Surgical Intervention in Encrusted Cystitis Caused by Corynebacterium Urealyticum.
    Eur J Case Rep Intern Med. 2025;12:005902.
    Abstract
    
    
89. SOKOL D, Rzhepishevska O, Marynova I, Monsen T, et al
    Metabolic interactions between bacterial co-isolates from catheter-associated urinary tract infections.
    Sci Rep. 2026;16:2061.
    Abstract
    
    
90. MIYAGISHIMA D, Manabe A, Ijima K, Saito M, et al
    Intractable Diarrhea due to Enterovesical Fistula Caused by Recurrent Urinary Tract Infection with Bladder Outlet Obstruction: A Rare Clinical Presentation of "Urinary Diarrhea".
    Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.6544.
    Abstract
    
    
91. DEAN S, Santeusanio A, Patel G, Wadhera V, et al
    Efficacy of a Single Dose of Intravesical Aminoglycoside for the Prevention of Urinary Tract Infections in Kidney Transplant Recipients.
    Clin Transplant. 2026;40:e70449.
    Abstract
    
    
92. OYEYEMI OT, Irabor PC, Oriade TO, Sulaiman KA, et al
    Enhancing serological diagnosis of urogenital schistosomiasis with admixtures of antigens from Schistosoma eggs and worms.
    J Infect Dev Ctries. 2025;19:1897-1903.
    Abstract
    
    
93. BAKHAT S, Uddin F, Sohail M, Ali S, et al
    Phenotypic detection of ESBL, AmpC, and MBL in Enterobacterales uropathogens: a two-center experience in Karachi, Pakistan.
    J Infect Dev Ctries. 2025;19:1789-1800.
    Abstract
    
    
94. KUMAR G, Shukla S, Agarwal S, Shukla D, et al
    Methicillin-Resistant Staphylococcus aureus in Urinary Tract Infections: A Comprehensive Review With Insights From a North Indian Cohort.
    Cureus. 2025;17:e99015.
    Abstract
    
    
95. LE NEVEU M, Toman C, Rhodes S, Gervas K, et al
    Perioperative Antibiotic Choice and Urinary Tract Infections in Prolapse Surgery.
    Urogynecology (Phila). 2026 Jan 13. doi: 10.1097/SPV.0000000000001786.
    Abstract
    
    
96. MISHRA C, Meena S, Mathur P
    Molecular Characterization of Carbapenem and Colistin Resistance in Isolates Causing Urinary Tract Infections at an Outpatient Setting of a Tertiary Care Hospital.
    Cureus. 2025;17:e98941.
    Abstract
    
    
97. ADDO KA, Boampong K, Ofori SA, Amissah-Reynolds PK, et al
    Soil-Transmitted Helminthes (STHs) and Asymptomatic Bacteriuria Amongst Preschool Children in the Bosomtwe District of Ghana.
    Biomed Res Int. 2026;2026:9946374.
    Abstract
    
    
98. ZIMMERN P, Shah A, Alhalabi F, Christie A, et al
    Comparison of Urine pH in Postmenopausal Women With a Current, a History of, or No History of Uncomplicated Urinary Tract Infection.
    JU Open Plus. 2026;4:e00001.
    Abstract
    
    
99. ZILBERMAN-ITSKOVICH S, Masarwi M, Levy E, Iflah M, et al
    Community-onset symptomatic urinary tract infections (SUTI) caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales: independent predictors and comparative effectiveness of oral agents.
    Antimicrob Steward Healthc Epidemiol. 2026;6:e15.
    Abstract
    
    
100. DOTIS J, Karava V, Kondou A, Christodoulaki V, et al
     Effects of a Cranberry, Probiotic, and Vitamin C Supplement on Recurrent Urinary Tract Infections in Children-A Cohort Study.
     J Diet Suppl. 2026 Jan 12:1-12. doi: 10.1080/19390211.2026.2615923.
     Abstract
     
     
101. SCHWEIZERHOF O, Meisel C, Blex C, Cinelli P, et al
     T-cell biomarkers improve urinary tract infection risk stratification beyond clinical characteristics after acute traumatic spinal cord injury.
     Sci Rep. 2026;16:1320.
     Abstract
     
     
102. MELENDEZ-CARMONA MA, Martin-Higuera MC, Recio R, Benavent E, et al
     Genomic profile of extraintestinal pathogenic Escherichia coli isolates from prosthetic joint infections: The search for molecular fingerprints.
     Virulence. 2026;17:2613491.
     Abstract
     
     
103. NIAZ H, Abbas A, Ayub A, Rahman A, et al
     Characterization and genome analysis of jumbo Escherichia phage UE-S1 and the antibacterial potential of its lysozyme against uropathogenic E. coli.
     BMC Microbiol. 2025;26:27.
     Abstract
     
     
104. ZHENG H, Liu Y, Zhang Y, Jiang S, et al
     Cynaroside attenuates uropathogenic Escherichia coli adhesion and invasion by suppressing bacterial virulence and down-modulating urothelial Caveolin-1 signaling.
     Phytomedicine. 2026;150:157594.
     Abstract
     
     
105. GENOVESE C, Offer M, Colaneri M, Dore F, et al
     Hospital Acquired Infections Among Solid Organ Transplant Recipients Hospitalized in Intensive Care Unit (2018-2024): A Study of the GiViTI Group.
     Transpl Infect Dis. 2025;27:e70120.
     Abstract
     
     
106. SCHUMACHER C, Northwood M, Nalunga R, Swindall T, et al
     Self-Care Activities of Community-Residing Adults With Indwelling Urinary Catheters: A Scoping Review.
     J Adv Nurs. 2026;82:1019-1038.
     Abstract
     
     
107. ABAZA I, Swift S, Digesu A
     Urobiome or Urinary Tract Infection: A Mysterious Dilemma.
     Int Urogynecol J. 2026 Jan 23. doi: 10.1007/s00192-026-06539.
     Abstract
     
     
108. ALBUQUERQUE K, Lamour J, Joseph T, Munoz L, et al
     Sustained Reduction of Catheter-Associated Urinary Tract Infections Through Data-Driven, Multidisciplinary Interventions: A Seven-Year Retrospective Study.
     Am J Infect Control. 2026 Jan 20:S0196-6553(26)00040.
     Abstract
     
     
109. HONG D, Kesselheim AS, Metlay JP, Powers JH, et al
     Physician Antibiotic Prescribing Preferences in Community Acquired Pneumonia and Complicated Urinary Tract Infections: A National Discrete Choice Experiment.
     Open Forum Infect Dis. 2026;13:ofaf783.
     Abstract
     
     
110. KLEPSER M, Tsuyuki R, Beahm NP, Adams AJ, et al
     FAQs About Pharmacist Management of Uncomplicated Lower Urinary Tract Infections.
     Ann Pharmacother. 2026 Jan 21:10600280251407250. doi: 10.1177/10600280251407250.
     Abstract
     
     
111. ABDELAZIZ AM, Kaddouri M, Sana EF, Khaoula H, et al
     Epidemiological profile and antimicrobial resistance of urinary tract infections in diabetic versus non-diabetic individuals.
     BMC Infect Dis. 2026 Jan 22. doi: 10.1186/s12879-026-12614.
     Abstract
     
     
112. MUKHOPADHYAY A, Kumar D, Rain Z, Rai S, et al
     pH-dependent efficacy of nitrofurantoin against uropathogenic Escherichia coli: Implications for personalized urinary tract infection treatment.
     Indian J Urol. 2026;42:67-72.
     Abstract
     
     
113. NWEKE CC, Egbuonu I, Ebenebe JC, Aghanya IN, et al
     Prevalence of urinary tract infection and the validity of urine analysis in the diagnosis of uti in febrile under-fives at Nnamdi Azikiwe University Teaching Hospital, Nnewi: a cross-sectional study.
     BMC Infect Dis. 2026 Jan 20. doi: 10.1186/s12879-026-12617.
     Abstract
     
     
114. FRIEDMAN S, Akerman K, Bouwmeester C
     2025 New Drug Update (Part 2): Recent Approvals and Clinical Implications.
     Sr Care Pharm. 2026;41:3-12.
     Abstract
     
     
115. DUNAICEVA J, Boillat-Blanco N, Li D, Niquille A, et al
     Do Swiss family physicians prescribe antibiotics in line with national guidelines? A cross-sectional study.
     Swiss Med Wkly. 2025;155:4234.
     Abstract
     
     
116. ROSS TA, Pontinen AK, Holsbo E, Samuelsen O, et al
     Machine learning-based lineage prediction from antimicrobial susceptibility testing phenotypes for Escherichia coli sequence type 131 clade C surveillance across infection types.
     Microb Genom. 2026;12:001608.
     Abstract
     
     
117. ALMAS S, Carpenter RE, Tamrakar VK, Sharma A, et al
     Evaluating extraction-free PCR for rapid detection of beta-lactam antibiotic resistance in urinary tract infection.
     Pract Lab Med. 2025;48:e00516.
     Abstract
     
     
118. LUCAS M, Noruegas MJ, Machado M
     Calyceal Diverticulum: A Cystic Lesion Mimicking a Urinary Tract Infection.
     Cureus. 2025;17:e99468.
     Abstract
     
     
119. CHAU EC, Hau PT, Murillo M, Tsang CC, et al
     Extracellular vesicles from bacteria and fungi: mechanistic insights and implications for urinary tract infections.
     Extracell Vesicles Circ Nucl Acids. 2025;6:860-875.
     Abstract
     
     
120. JERLIU A, Harrison L, Eljafarawi E, Castiglione C, et al
     Impact of Preoperative Urinary Tract Infection on Postoperative Outcomes in Plastic Surgery.
     Plast Reconstr Surg Glob Open. 2026;14:e7384.
     Abstract
     
     
121. LIM LL, Friedman ND, Tanamas SK, Worth LJ, et al
     Monitoring urinary tract infections in residents of Australian aged care homes: Clinical and microbiological characteristics identified through a pilot surveillance program.
     Infect Dis Health. 2026;31:100404.
     Abstract
     
     
122. SWILAM ESA, Aldesoky MM, Hassan EM, Elnady EA, et al
     Evaluation of serum interleukin-6 level in diabetic patients with urinary tract infections.
     Egypt J Immunol. 2026;33:1-11.
     Abstract
     
     
123. MOHAMED T, Bani Irshid BA, Elhashamy H, Deameh MG, et al
     Optimal duration of perioperative antibiotics in radical cystectomy and urinary diversion: a systematic review and meta-analysis.
     Langenbecks Arch Surg. 2026;411:58.
     Abstract
     
     
124. POMARI E, Webster BL, Locatelli E, Alvarez-Martinez MJ, et al
     Investigating genetic profiles of cases of Schistosoma spp. imported into Europe: a cohort from the European Society of Clinical Microbiology and Infectious Diseases Study Group for Clinical Parasitology.
     Parasit Vectors. 2025;19:37.
     Abstract
     
     
125. AMEGBLETOR HK, Labi AK, Hukporti N, Osei MM, et al
     Characterization of urinary Escherichia coli isolates in HIV-seropositive women with asymptomatic bacteriuria in Western Ghana.
     BMC Microbiol. 2025;26:37.
     Abstract
     
     
126. LE BIHAN C, Aubin GG, Jeanmougin P, Fournier JP, et al
     [General practitioners' requests for advisory services to biologists regarding selective reporting of antibiotic susceptibility testing].
     Ann Biol Clin (Paris). 2026;83:608-620.
     Abstract
     
     
127. BIJU AK, Ramakrishnan J, Alagumuthu M
     Identification of therapeutic targets and potential phytochemicals for UTI treatment from Myristica fragrans through CADD.
     Comput Biol Chem. 2026;121:108820.
     Abstract
     
     
128. ALFONSO ARVEZ MJ, Tan GSQ, Ademi Z, Ilomaki J, et al
     Initiation of sodium-glucose cotransporter-2 inhibitors and the risk of infection-related hospitalisations: A population-based cohort study.
     Diabetes Obes Metab. 2026;28:1057-1067.
     Abstract
     
     
129. CAROFF DA, Dargin JM, Rieder L, Dhungana R, et al
     Implementation of a diagnostic algorithm to reduce CAUTI surveillance events.
     Infect Control Hosp Epidemiol. 2025;46:938-940.
     Abstract
     
     
130. MIRANTI E, Sampson MM, Shepard J, Rodriguez-Nava G, et al
     Low diagnostic yield of repeat urine cultures in hospitalized patients at a tertiary center in Northern California, 2023-2024.
     Infect Control Hosp Epidemiol. 2025;46:935-937.
     Abstract
     
     
131. ELHALABY RE, Zeina WO, Nessim L, Ahmed ME, et al
     PD-L1 expression in schistosomal granuloma: an immunohistochemical study in urinary bladder schistosomiasis.
     J Clin Pathol. 2026;79:114-119.
     Abstract
     
     
132. QIAN T, He Y, Yan R, Yu S, et al
     Recurrent urinary tract infections and psychological burden: mechanisms and integrative perspectives.
     Front Med (Lausanne). 2026;12:1721343.
     Abstract
     
     
133. MEDDINGS J, Chrouser K, Fowler KE, Ameling J, et al
     Ann Arbor Guide to Triaging Adults With Suspected Urinary Tract Infection for In-Person and Telehealth Settings.
     JAMA Netw Open. 2026;9:e2556135.
     Abstract
     
     
134. YEPES G, Tang HC, Holdsworth N, Salamon K, et al
     Urinary Antimicrobial Peptides and Cytokines as Biomarkers for Recurrent Urinary Tract Infection in Children and Adolescents.
     medRxiv [Preprint]. 2026 Jan 2:2025.12.29.25343150.
     Abstract
     
     
135. FAYYAD-KAZAN H, Shaalan F, Darwiche Z, Kdouh F, et al
     Prevalence and antimicrobial resistance patterns in patients with urinary tract infections: a three-year retrospective study at a tertiary healthcare center in Lebanon.
     BMC Infect Dis. 2026 Jan 29. doi: 10.1186/s12879-026-12712.
     Abstract
     
     
136. DOIRON RC, Nickel JC, Kamdar S
     The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women: A cost-utility analysis.
     Can Urol Assoc J. 2026 Jan 23. doi: 10.5489/cuaj.9237.
     Abstract
     
     
137. LI G, Zhang S, Liu J, Wang X, et al
     Asymmetric Cu horizontal line N horizontal line Ru Bridgedsite Nanozyme-Loaded Injectable Thermogel Boosts Cuproptosis-Like Death for Multidrug-Resistant Urinary Tract Infections.
     Adv Sci (Weinh). 2026 Jan 28:e20705. doi: 10.1002/advs.202520705.
     Abstract
     
     
138. CLARK AL
     Frequent urinary tract infections in midlife and older women.
     Menopause. 2026;33:132-133.
     Abstract
     
     
139. WU X, Qian Z, Zhou W, Yue L, et al
     Myricetin-3-O-galactoside in cranberries alleviates urinary tract infections in mice by inhibiting the adhesion of uropathogenic Escherichia coli CFT073.
     Food Funct. 2026 Jan 28. doi: 10.1039/d5fo04827.
     Abstract
     
     
140. SAHU M, Paliwal T, Joshi R, Vishwapriya AK, et al
     Natural Protective Mechanisms of Cucumis callosus Leaves in Escherichia Species-Induced Urinary Tract Infection: An Integrated In Silico and In Vivo Study.
     Pathogens. 2026;15:111.
     Abstract
     
     
141. ERINMEZ M, Ozturk M
     Urinary Tract Infection in Patients with Urolithiasis: A Large Retrospective Observational Study of Clinical Features and Microbiological Spectrum.
     Pathogens. 2026;15:98.
     Abstract
     
     
142. MONROY-HIGUERA J, Angulo-Zamudio UA, Leon-Sicairos N, Flores-Villasenor H, et al
     Epidemiological and Clinical Characteristics Associated with Antimicrobial-Resistant Urinary Tract Infections in Outpatient and Inpatient Settings: A Retrospective Study from Northwestern Mexico.
     Pathogens. 2026;15:92.
     Abstract
     
     
143. HERNANDEZ-SANCHEZ JE, Lorenzo-Gomez MF, Gonzalez-Enguita C
     Current Evidence on Safety, Efficacy and Efficiency of Sublingual Vaccine Uromune((R)) in Prevention of Recurrent Urinary Tract Infections: A Literature Review.
     Pathogens. 2025;15:42.
     Abstract
     
     
144. ANTON CI, Sima CS, Ion S, Jinga V, et al
     Predictors of Multidrug-Resistant Urinary Tract Infections in Women: A Large Retrospective Cohort Study in a Romanian University Hospital.
     Microorganisms. 2026;14:157.
     Abstract
     
     
145. GATSOS S, Constantinou E, Koutsoumparis D, Samarinas M, et al
     Effect of Bladder Injections of Botulinum Neurotoxin A on Biomarkers Associated with Inflammation and Urinary Infections in Patients with Neurogenic Detrusor Overactivity-Associated Incontinence: A Pilot, Prospective, Human Study.
     Int J Mol Sci. 2026;27:1110.
     Abstract
     
     
146. PEI Q, Liu J, Tang Z, Tan J, et al
     Trained Immunity in Bladder ILC3s Enhances Mucosal Defense Against Recurrent Urinary Tract Infections.
     Biomedicines. 2025;14:78.
     Abstract
     
     
147. BARATA PI, Chicea LM, Nedelea I, Strauti CN, et al
     Recurrent Urinary Tract Infections in a Patient with Diffuse Large B-Cell Lymphoma and Severe COVID-19: A Single Case of Suspected Immunosuppression Where Antibacterial Therapy Was Not Enough.
     Antibiotics (Basel). 2026;15:48.
     Abstract
     
     
148. MEDINA-POLO J, Arrebola-Pajares A, Falkensammer E, Tandogdu Z, et al
     A Systematic Review of the Current Evidence of the Effectiveness and Safety of Immunoprophylaxis Using Sublingual Dead Whole Bacteria to Prevent Recurrent Urinary Tract Infections (rUTIs).
     Antibiotics (Basel). 2025;15:6.
     Abstract
     
     
149. COENEN I, Lenie S, Coteur K, Hughes C, et al
     Behavioural Determinants of Appropriate Antibiotic Prescribing for Urinary Tract Infections in Nursing Homes: A Qualitative Study of Stakeholders' Perspectives.
     Antibiotics (Basel). 2025;15:5.
     Abstract
     
     
150. ZAKI S, Kotb DN, Abdelrahim SS
     Dissemination of integrons and carbapenemase-encoding genes among multidrug resistant Proteus mirabilis isolated from urinary tract infections in Egypt.
     BMC Infect Dis. 2026;26:179.
     Abstract
     
     
151. HOWARD A, Green PL, Zhong Y, Hughes DM, et al
     Algorithmic antibiotic decision-making in urinary tract infection using prescriber-informed prediction of treatment utility.
     NPJ Digit Med. 2026 Jan 26. doi: 10.1038/s41746-026-02369.
     Abstract
     
     
152. ZHANG X, Miao S, Ji C, Hu W, et al
     Risk factors and treatment advances for carbapenem-resistant Enterobacteriaceae infections in the urinary tract.
     Front Cell Infect Microbiol. 2026;15:1724851.
     Abstract
     
     
153. YAKUBU B
     Antimicrobial Resistant Factors in Klebsiella pneumoniae Strains Isolated From Urinary Tract Infections, Wound Infections, Hospital Wastewater, and Cervical Cancers From Ghana, Togo, and Benin.
     Int J Genomics. 2026;2026:5079377.
     Abstract
     
     
154. LEE HS, Lee JS
     Institutional and individual factors influencing urinary tract infections and pressure injuries in Korean nursing home residents: A multilevel analysis of National Health Insurance Service Data.
     J Korean Gerontol Nurs. 2025;27:349-363.
     Abstract
     
     
155. ZHAO R, Sui J
     Effects of cluster six nursing on catheter-associated urinary tract infection in critically ill patients.
     Afr J Reprod Health. 2026;30:53-60.
     Abstract
     
     
156. MIURA K
     Hematuria as a Diagnostic Clue to Non-cirrhotic Hyperammonemia Due to Corynebacterium urealyticum Urinary Tract Infection: A Case Report.
     Cureus. 2025;17:e100082.
     Abstract
     
     
157. ZHENG J, Liu J, Zeng X, Zeng T, et al
     Can dynamic changes in preoperative urinary white blood cells and nitrite predict infectious complications after percutaneous nephrolithotomy in culture-positive patients?
     World J Urol. 2026;44:126.
     Abstract
     
     
158. ROCHA DA SILVA C, Andrade Neto JB, Pessoa de Farias Cabral V, Mota da Costa ER, et al
     Preventive activity of promethazine against fluconazole-resistant Candida spp. biofilms fixed on urinary catheters.
     Biofouling. 2026;42:148-157.
     Abstract
     
     
159. HITZENBICHLER F
     [Duration of antibiotic therapy: how short is short enough?].
     Inn Med (Heidelb). 2026;67:137-143.
     Abstract
     
     
160. BERA S, Gautam A, Pal G, Prasad P, et al
     Luminescent array sensors for pathogen identification using AIE-active cationic iridium complexes.
     Chem Commun (Camb). 2026;62:2212-2216.
     Abstract
     
     
161. GLEICH L, Shenhar C, Booher J, Slopnick E, et al
     Bladder OnabotulinumtoxinA Antibiotic Prophylaxis: A Prospective RCT.
     Urogynecology (Phila). 2026;32:149-154.
     Abstract
     
     
162. KUMAR A, Kumar A, Islam MM, Borgohain R, et al
     Modern Solutions to UTIs: The Role of Nanotechnology and Herbal Treatments.
     Curr Drug Targets. 2025;26:828-849.
     Abstract
     
     
163. MAYBERRY SA, Kusin S, Ramisetty-Mikler S, Malik AA, et al
     Recurrent UTI quality of life questionnaire: pilot study evaluating the impact of recurrent urinary tract infection on quality of life in postmenopausal women.
     World J Urol. 2026;44:152.
     Abstract
     
     
164. AWOLARAN O, MacGregor K, Lum SA, Keijzer R, et al
     Maternal Risk Factors Associated with Complex Gastroschisis: Cannabis Exposure and Recurrent Urinary Tract Infections May Be Modifiable Targets.
     J Pediatr Surg. 2026 Feb 4:163000. doi: 10.1016/j.jpedsurg.2026.163000.
     Abstract
     
     
165. RANI K, Hari A, Bygari SR, Pradhan SM, et al
     Point-of-care tests for urinary tract infections: A systematic review and meta-analysis of diagnostic accuracy and antimicrobial susceptibility assessment.
     Diagn Microbiol Infect Dis. 2026;115:117296.
     Abstract
     
     
166. FAKHRALDDIN SS, Abdullah PA, Ibrahim DN, Maarouf KB, et al
     Incidence and pattern of antimicrobial resistance of main bacterial isolates from patients with communityacquired urinary tract infections in North of Iraq.
     Arch Ital Urol Androl. 2026 Feb 3:14715. doi: 10.4081/aiua.2026.14715.
     Abstract
     
     
167. SOLORZANO C, Rubio MC, Leon JL, Caro MA, et al
     Diagnostic Efficiency in Urinary Tract Infection: Evaluation of a Comprehensive Intervention Based on Clinical Conditions, Urinalysis, and Gram Staining.
     Cureus. 2026;18:e100750.
     Abstract
     
     
168. ONATIBIA-ASTIBIA A, Alzate L, Lasa E, Oyarbide I, et al
     Urinary tract infection screening and referral service from community pharmacy.
     Farm Comunitarios. 2026;18:e232.
     Abstract
     
     
169. ABIRAMALATHA T, Indhumathi S, Bhuvaneswari C, Govindaraju G, et al
     Diagnostic Utility of Routine Urine Analysis in Detecting Urinary Tract Infections in Neonates: A Prospective Observational Study.
     Indian J Pediatr. 2026 Feb 5. doi: 10.1007/s12098-025-05977.
     Abstract
     
     
170. PHOURATSAMAY A, Le Loc'h A, Paoletti C, Rosas-Navarro J, et al
     Escherichia coli and Enterococcus faecalis are identified as the most frequently isolated bacteria associated with urinary tract infections in pet rabbits.
     J Am Vet Med Assoc. 2026 Feb 4:1-9. doi: 10.2460/javma.25.10.0700.
     Abstract
     
     
171. MAHZOON M, Yousefi J, Azarfar A, Khazaei MR, et al
     Prognostic value of serum vitamin D level for renal scarring in childhood acute pyelonephritis.
     Turk J Pediatr. 2025;67:855-865.
     Abstract
     
     
172. PADUTHOL G, Nikolaev M, Sharma K, Blanc J, et al
     A microphysiological human mini-bladder reveals urine-urothelium interplay in tissue resilience and UPEC recurrence in urinary tract infections.
     Nat Commun. 2026 Feb 3. doi: 10.1038/s41467-026-68573.
     Abstract
     
     
173. VAZQUEZ-MONTES MD, Fanshawe TR, Smith MC, Ahmed H, et al
     Defining recurrent urinary tract infection and reinfection risk: electronic health record study.
     BJGP Open. 2026 Feb 3:BJGPO.2025.0239. doi: 10.3399/BJGPO.2025.0239.
     Abstract
     
     
174. TRIPPLER L, Hattendorf J, Ali MN, Najim SO, et al
     Evaluation of surveillance-response interventions for Schistosoma haematobium elimination on Pemba Island, Tanzania: A 4-year intervention study with repeated cross-sectional surveys.
     PLoS Negl Trop Dis. 2026;20:e0013947.
     Abstract
     
     
175. SADDAM M, Mishra SK, Singh N, Prasad SB, et al
     A comprehensive review on herbal approaches for treatment of urinary tract infections: Scope and challenges.
     J Pharm Anal. 2026;16:101414.
     Abstract
     
     
176. PALUCK F, Guytingco A, Carscadden E, Ostrow O, et al
     Non-invasive urinary tract infection screening for young infants: A high-value care initiative.
     Paediatr Child Health. 2025;31:8-14.
     Abstract
     
     
177. YIN S, Hao X, Cai X, Wang X, et al
     Do ureteral stents improve clinical outcomes in renal transplantation? A systematic review and meta-analysis comparing stented and non-stented anastomosis techniques.
     PeerJ. 2026;14:e20665.
     Abstract
     
     
178. KIM S, Kremen S, Danovitch I, Lahiri S, et al
     Urinary tract infection-related delirium in Alzheimer's disease and related dementias: Clinical challenges and translational opportunities.
     Alzheimers Dement. 2026;22:e71184.
     Abstract
     
     
179. SCHWARZTUCH GILDOR O, Yosef E, Levin N, Itshak A, et al
     Development and Validation of a Nomogram for Predicting Urinary Tract Infection After Urodynamic Study.
     Neurourol Urodyn. 2026 Feb 2. doi: 10.1002/nau.70229.
     Abstract
     
     
180. AGRAWAL S, Ikpeama N, Koelper N, Dokras A, et al
     A Randomized Trial of a Texting Platform for Recurrent Urinary Tract Infections.
     Urogynecology (Phila). 2026 Feb 2. doi: 10.1097/SPV.0000000000001770.
     Abstract
     
     
181. PALACIO I, Michel G, Portalatin K, Arraut K, et al
     Periprosthetic Penile Abscess as an Unusual Cause of Refractory Urinary Tract Infection in an Elderly Patient With Diabetes: A Case Report.
     Cureus. 2026;18:e102082.
     Abstract
     
     
182. CHANDRAKUMAR S, Manickam S, Nishanthi A, Thiyagarajan M, et al
     Sensitivity and resistance pattern of uropathogens causing urinary tract infections among adults at a teaching hospital in South India - A retrospective analysis.
     J Family Med Prim Care. 2025;14:5040-5046.
     Abstract
     
     
183. JOVANOVIC A, Drobac M, Vidovic B, Krajnovic D, et al
     Development and initial content and face validation of a questionnaire to evaluate pharmacists' attitudes and practices in counselling urinary tract infection patients: A mixed methods study.
     Explor Res Clin Soc Pharm. 2026;21:100702.
     Abstract
     
     
184. HARA J, Muramoto K, Santo S, Hagiwara T, et al
     Impact of preoperative urine culture on postoperative febrile urinary tract infection after ureterorenoscopic lithotripsy.
     J Infect Chemother. 2026;32:102918.
     Abstract
     
     
185. VAN BREMEN HE, Seppala LJ, van der Velde N, Hegeman JH, et al
     Association between ten complications and mortality : insights from the Dutch Hip Fracture Audit.
     Bone Joint J. 2026;108-B:216-225.
     Abstract
     
     
186. GUPTA S, Rajak S, Cortado H, Becknell B, et al
     Interleukin-6 limits host susceptibility to urinary tract infection by promoting urothelial expulsion of intracellular bacteria.
     J Innate Immun. 2026 Jan 30:1-11. doi: 10.1159/000550787.
     Abstract
     
     
187. MURANAKA E, Kurihara M, Okawa N, Nishihara Y, et al
     Oligella urethralis bacteremia associated with urinary tract obstruction: A case report and literature review.
     J Infect Chemother. 2026;32:102909.
     Abstract
     
     
188. THAMAYANDHI CE, Manna A, Singh AK, Lakshmanan D, et al
     Type 1 fimbrial protein FimH of Enterobacteriaceae-a promising target to mitigate different infections.
     J Appl Microbiol. 2026;137:lxag016.
     Abstract
     
     
189. DURAN RAMIREZ JM, Armbruster CE, Hanson BM, Walker JN, et al
     Genomics reveal Staphylococcus aureus persists during long-term urinary catheterization despite antimicrobial therapy and catheter exchanges.
     Nat Commun. 2026;17:1328.
     Abstract
     
     
190. NAIR VG, Chellappan DR, Durai RD, Y B R D R, et al
     Synergistic antipersister, efflux inhibitory & antibiofilm activities of vaginal Lactobacillus-derived postbiotics against UPEC: toward a novel therapeutic for utis.
     Sci Rep. 2026;16:5005.
     Abstract
     
     
191. CUBUK F, Oksuz C, Oz M
     Diagnostic utility of urinalysis parameters in predicting urine culture positivity: A gender-stratified evaluation.
     J Infect Chemother. 2026;32:102904.
     Abstract
     
     
192. SPADONI N, Kaur H, Ramadan B
     Asymptomatic bacteriuria as a warning sign of purulent pericardial effusion in a patient with systemic lupus erythematosus: a case report.
     J Med Case Rep. 2026;20:51.
     Abstract
     
     
193. CHIU S-K, Liu EY-M, Lin F-M, Li J-J, et al
     The sero-prevalence and virulence determinants of Klebsiella pneumoniae isolated from urine in outpatient units: a 20-year collection from Taiwan as a herald for serotype vaccine selection.
     Microbiol Spectr. 2026;14:e0263325.
     Abstract
     
     
194. YATHINDRA MR, Badugu R, Singh SK, Paluri S, et al
     The role of the urinary microbiome in diabetes-associated UTIs: current understanding and future directions.
     J Basic Clin Physiol Pharmacol. 2025;37:9-24.
     Abstract
     
     
195. CHAO YJ, Lee YJ, Chen HH, Kao CY, et al
     Hha toxin regulates diverse phenotypes of uropathogenic Proteus mirabilis including virulence.
     J Microbiol Immunol Infect. 2026;59:124-135.
     Abstract
     
     
196. AFFUL E, Barker ES, Issa T, Narcisse S, et al
     Hormonal Contraception Use and Risk of Lower Urinary Tract Symptoms and Conditions: Findings From the Boston Area Community Health Survey.
     Int Urogynecol J. 2026;37:193-207.
     Abstract
     
     
197. FEHER AM, Safikhani M, Bajory Z, Lazar A, et al
     Urinary bacterial spectrum and antibiotic resistance trends at a Urology Clinic in Hungary between 2012 and 2023.
     Int Urol Nephrol. 2026;58:517-525.
     Abstract
     
     
198. MAMONA-KILU C, Hoang BH, Farfour E, Dinh A, et al
     Temocillin for non-urinary tract infections caused by AmpC-producing Enterobacterales: Is it a feasible option?
     Infect Dis Now. 2026 Feb 13:105257. doi: 10.1016/j.idnow.2026.105257.
     Abstract
     
     
199. RAMIREZ FINN L, Ingersoll MA
     How Does Biological Sex Impact Mucosal Bacterial Infection? Mucosal Defenses and Bacterial Detection.
     Immunol Rev. 2026;338:e70112.
     Abstract
     
     
200. HUANG Q, Ding M, Lian X, Huang Y, et al
     Efficacy and safety of flexible and navigable suction ureteral access sheath combined with flexible ureteroscopic lithotripsy versus flexible ureteroscopic lithotripsy alone for infected upper urinary tract stones: a retrospective cohort study.
     World J Urol. 2026;44:167.
     Abstract
     
     
201. THEUT M, Jensen JN, Antsupova V, Hansen MP, et al
     Signs and symptoms attributed to urinary tract infections in nursing home residents across eight European countries.
     Eur Geriatr Med. 2026 Feb 13. doi: 10.1007/s41999-026-01427.
     Abstract
     
     
202. AL-ANAZI F, Talha A
     ANTIBIOGRAM OF URINARY CATHETER-ASSOCIATED BACTERIAL PATHOGENS IN INTENSIVE CARE UNIT, KING KHALID GENERAL HOSPITAL, HAFER AL-BATEN, SAUDI ARABIA.
     Georgian Med News. 2025;:87-95.
     Abstract
     
     
203. RALSTON H, Butterworth A, Clark B, Katsafadou M, et al
     Toward Enhanced Selection of Antibiotics in a Hospital Laboratory-Development of a Rapid Electrochemical Antimicrobial Sensitivity Test for Urinary Tract Infections.
     ACS Sens. 2026 Feb 13:XXX. doi: 10.1021/acssensors.5c02725.
     Abstract
     
     
204. TORRES SANDOVAL CA, Arcila MJ, Osorio AD, Catano JG, et al
     Incidence of Urinary Tract Infection After Combined Cystoscopy and Urodynamic Testing: A Prospective Cohort Study.
     Neurourol Urodyn. 2026 Feb 13. doi: 10.1002/nau.70244.
     Abstract
     
     
205. AND ALTERNATIVE MEDICINE EC
     RETRACTIONS: Isolation, Identification, Characterization, and Plasmid Profile of Urinary Tract Infectious Escherichia coli from Clinical Samples.
     Evid Based Complement Alternat Med. 2026;2026:9754209.
     Abstract
     
     
206. DAHLQUIST K, Stuart A, Kallen K
     Urinary tract infection during pregnancy and time relation to preterm birth-a Swedish observational study.
     Acta Obstet Gynecol Scand. 2026 Feb 13. doi: 10.1111/aogs.70156.
     Abstract
     
     
207. REVER J, Khalid N, Kulig C, Girgis J, et al
     Safety of Initiating Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure or Type 2 Diabetes and a History of Urinary Tract Infections.
     Healthcare (Basel). 2026;14:318.
     Abstract
     
     
208. SULEYMAN G, Shallal A, Ruby A, Chami E, et al
     Changing the culture of urine culturing: a hard stop approach to catheter-associated urinary tract infections (CAUTI) reduction.
     Am J Infect Control. 2026 Feb 10:S0196-6553(26)00085.
     Abstract
     
     
209. WEAVER MS, Johnson LM, Williams A, Cohen AD, et al
     Upstream from Urosepsis: Removing Race from Pediatric Urinary Tract Infection Algorithms.
     Am J Bioeth. 2026;26:117-120.
     Abstract
     
     
210. YANG L, Yin J, Yang Z, Liu J, et al
     Development and validation of a prediction model for urinary tract infection in older patients with type 2 diabetes mellitus.
     Front Endocrinol (Lausanne). 2026;17:1706338.
     Abstract
     
     
211. KIM M, An JH, Yu SH, Kim SE, et al
     Mycobacterium abscessus subsp. massiliense Urinary Tract Infection in an Immunocompetent Patient.
     Chonnam Med J. 2026;62:43-44.
     Abstract
     
     
212. ESKANDAR K
     The role of uropathogenic Escherichia coli biofilms in antibiotic-resistant urinary tract infections: Nanoparticle-based, phage therapy, and quorum-sensing inhibitor approaches.
     Curr Urol. 2026;20:82-88.
     Abstract
     
     
213. PRAKASAM L, Murugesan A, Vajravelu LK, D MK, et al
     Unlocking the probiotic potential of breast milk-derived lactobacillus against urinary tract infections: mechanisms, therapeutic prospects, and future directions.
     Antonie Van Leeuwenhoek. 2026;119:52.
     Abstract
     
     
214. DE OLIVEIRA GC, Hobaica NC, Porto BC, Passerotti CC, et al
     Correction: Effectiveness of methenamine hippurate in preventing urinary tract infections: an updated systematic review, meta-analysis and trial sequential analysis of randomized controlled trials.
     BMC Urol. 2026;26:37.
     Abstract
     
     
215. LI FF, Li JJ, Zhang Y, Wu ZY, et al
     Analysis of the Type VI secretion system and microbiological characteristics of hypervirulent Klebsiella pneumoniae causing urinary tract infections.
     J Infect Dev Ctries. 2026;20:70-78.
     Abstract
     
     
216. KUCUKATES E, Karatas A, Alacam S
     Intensive care units-acquired urinary tract infections: a 5-year multicenter retrospective study in Istanbul.
     J Infect Dev Ctries. 2026;20:52-61.
     Abstract
     
     
217. KHAN ZR, Ullah Z, Alwakeedi A, Majeed I, et al
     Urine Analysis as a Reliable Indicator of a Urinary Tract Infection: A Cross-Sectional Study.
     Cureus. 2026;18:e101074.
     Abstract
     
     
218. HAMID F, Basargin K, Farghaly N, Azhar E, et al
     Obstetric Sutures Gone Astray: A Bladder Erosion of a Cerclage Suture Leading to Recurrent Urinary Tract Infections.
     Cureus. 2026;18:e101097.
     Abstract
     
     
219. SKALLI S, Hmamouchi I, Abouqal R, Hajjaj-Hassouni N, et al
     Urinary Tract Infection in Neurologic Patients Undergoing Intermittent Catheterization: A Systematic Review and Meta-Analysis of Catheter Type and Technique.
     Cureus. 2026;18:e101064.
     Abstract
     
     
220. AHUMADA-COTA RE, Hernandez-Chinas U, Recillas-Farfan B, Navarro-Ocana A, et al
     KguS/KguR two-component system as a molecular marker for E. coli strains associated with chronic urinary tract infections (cUTI).
     J Microbiol Methods. 2026;243:107421.
     Abstract
     
     
221. MING H, Na W, Tingting H, Huiyi W, et al
     Low-inflammatory response phenotypes in elderly urinary tract infections: pathogen type, antimicrobial resistance, and comorbidity-associated risk profiles.
     BMC Geriatr. 2026 Feb 7. doi: 10.1186/s12877-025-06901.
     Abstract
     
     
222. ZHAO W, Yu X, Zhang Y, Cai S, et al
     Frontiers and literature review on non-aspiration stroke-associated infections.
     Eur J Med Res. 2026;31:296.
     Abstract
     
     
223. CHEN WH, Xu J, Zheng LT, You HJ, et al
     The impact of urine output trajectory on clinical outcomes in female patients with genitourinary infections in the intensive care unit.
     Sci Rep. 2026;16:5651.
     Abstract
     
     
224. MANERS C, Kyser AJ, Verhoeven D, Fotouh B, et al
     Fabrication of bioprints self-coated with thermally sensitive lactobacilli for CAUTI applications.
     Eur J Pharm Biopharm. 2026;221:114993.
     Abstract
     
     
225. LUNAS JM, Holborn C, Appleyard R, Baker H, et al
     Comparison of self-removal and clinic-removal of catheter after Robot-Assisted Laparoscopic prostatectomy.
     Eur J Oncol Nurs. 2026;80:103072.
     Abstract
     
     
226. OUEDRAOGO S, Soubeiga AP, Simpore A, Kpoda DS, et al
     Prevalence of extended spectrum beta lactamase and molecular detection of bla(TEM), bla(SHV) and bla(CTX-M) genes among gram negative bacilli uropathogen isolates in Ouagadougou, Burkina Faso.
     Int Microbiol. 2026;29:231-242.
     Abstract
     
     
227. AGGARWAL A, Biswal D, Rawre J, Vikram N, et al
     Prevalence of Chlamydia trachomatis, Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium in patients with sterile pyuria.
     Indian J Med Microbiol. 2026;59:101030.
     Abstract
     
     
228. JUNG S, Chen K, Kazim M, Shah M, et al
     Pilot Study to Assess the Impact of UTI Recurrence on Quality of Life and Medical Utilization in Kidney Transplant Recipients.
     Transpl Infect Dis. 2026;28:e70137.
     Abstract
     
     
229. MIR AA, Wani S, Bali N, Ahad B, et al
     Molecular characterisation of fosfomycin resistant Enterococci faecalis isolated from a tertiary care medical hospital in northern India.
     Indian J Med Microbiol. 2026;59:101022.
     Abstract
     
     
230. ANANDA T, Mukhopadhyay C
     A molecular snapshot of clinical extra-intestinal Escherichia coli strains in South India - Virulence factors, phylogrouping and resistance trends.
     Indian J Med Microbiol. 2026;59:101024.
     Abstract
     
     
231. SAMAN, Siddique AB, Aslam B, Nawaz Z, et al
     Biofilm Formation and Antibiotic Resistance in Uropathogenic Escherichia coli: A Molecular Characterization and Antibiogram Study.
     Microb Drug Resist. 2026;32:24-30.
     Abstract
     
     
232. COLBORN KL, Fei Y, Henderson WG, Zhuang Y, et al
     Estimation of risk-adjusted postoperative infection outcomes using interpretable machine learning and electronic health record data.
     Am J Infect Control. 2026;54:139-144.
     Abstract
     
     
233. PARRA B, Sandoval M, Matus-Kohler M, Rivera D, et al
     Isolation, characterization and genomic analysis of a novel lytic bacteriophage EcoPhCCP1, capable of infecting multiple strains of multidrug-resistant Escherichia coli recovered from urinary tract infections.
     J Gen Virol. 2026;107.
     Abstract
     
     
234. NUSS ZJ, Berthold S
     Intravenous Fosfomycin in Complicated Urinary Tract Infection.
     Ann Pharmacother. 2026 Feb 19:10600280261421571. doi: 10.1177/10600280261421571.
     Abstract
     
     
235. LAN S, Wang H, Li H, Wang J, et al
     Clinical profiles and modifiable risk factors for catheter-associated urinary tract infections in hospitalized obstetrics and gynecology patients: a case-control study.
     BMC Infect Dis. 2026 Feb 18. doi: 10.1186/s12879-026-12797.
     Abstract
     
     
236. SOLANKI P, Wirth M, Weaver FM, Suda KJ, et al
     Experiences and Quality of Life Impacts Related to Urinary Tract Infections in Veterans With Neurogenic Bladder: A Mixed Methods Study.
     Neurourol Urodyn. 2026 Feb 18. doi: 10.1002/nau.70246.
     Abstract
     
     
237. PERIASAMY S, Lubbers J, King S, Hovingh ES, et al
     Harnessing pro-inflammatory and immunopathologic immune responses in urinary tract infections for vaccine development: it's all about a balance.
     Front Immunol. 2026;17:1753331.
     Abstract
     
     
238. FENG C, Li W, Wang Y, Sun L, et al
     Wettable Porous Arrays with Structural Color Barcodes Integration for Multiplex Urinary Tract Infection Bacteria Screening.
     Anal Chem. 2026 Feb 17. doi: 10.1021/acs.analchem.5c07570.
     Abstract
     
     
239. HERNANDEZ R
     Communication About Urinary Tract Infections: Communicative (Dis)enfranchisement Meets Privacy Management.
     Qual Health Res. 2026 Feb 17:10497323261418631. doi: 10.1177/10497323261418631.
     Abstract
     
     
240. ELUMALAI L, Anbazhagan GK, Subramaniyan S, Govindasamy M, et al
     GC-MS Profiling and In Silico Evaluation of Methanolic Syzygium aromaticum Extract Against Urinary Tract Pathogens.
     Chem Biodivers. 2026;23:e02194.
     Abstract
     
     
241. DEBERU ON, Addae EK, Zeyeh DE, Nyantakyi CO, et al
     An uncommon case of Chromobacterium violaceum urinary tract infection in a tertiary hospital in Ghana: a case report.
     J Med Case Rep. 2026 Feb 16. doi: 10.1186/s13256-026-05855.
     Abstract
     
     
242. SOKOL D, Rzhepishevska O, Marynova I, Monsen T, et al
     Correction: Metabolic interactions between bacterial co-isolates from catheter-associated urinary tract infections.
     Sci Rep. 2026;16:6579.
     Abstract
     
     
243. NARTEY LK, Weke K, Yuen V, Kibsey P, et al
     Proteomic Adaptations of Escherichia coli in Urinary Tract Infection Patients.
     J Proteome Res. 2026 Feb 16. doi: 10.1021/acs.jproteome.5c01165.
     Abstract
     
     
244. MARSH MC, Abbas L, Perry MF, Haberman C, et al
     Timing of Renal and Bladder Ultrasound After First Febrile Urinary Tract Infection: A Hospitalist Dilemma.
     Hosp Pediatr. 2026 Feb 17:e2025008534. doi: 10.1542/hpeds.2025-008534.
     Abstract
     
     
245. REYES-MARTINEZ P, Sierra-Diaz E, Ortiz-Lazareno PC, Garcia-Gutierrez M, et al
     Microbiological profile and epidemiological perspective on urinary tract infections (UTIs) in a tertiary medical center in Western Mexico.
     Front Microbiol. 2026;17:1734551.
     Abstract
     
     
246. YUMLEMBAM BD, Chongtham U, Rajkumar MS
     Prevalence, Demographic Distribution, and Antimicrobial Resistance Patterns of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Urinary Tract Infections: A Cross-Sectional Study in a Tertiary Care Hospital in Manipur, India.
     Cureus. 2026;18:e101302.
     Abstract
     
     
247. KAMO H, Burke RM, Mehta TR, Remz M, et al
     Urinary Tract Infections in Hospitalized Patients with Parkinson's Disease: Risk Factors and Outcomes.
     Mov Disord Clin Pract. 2026 Feb 16. doi: 10.1002/mdc3.70556.
     Abstract
     
     
248. KUNZ COYNE AJ, Bouchard J, Durham SH, Kang AY, et al
     Oral beta-Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point-Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones.
     Pharmacotherapy. 2026;46:e70118.
     Abstract
     
     
249. JALALI M, AbdElFatah T, Del Real Mata C, I Hosseini I, et al
     Ultra-rapid nanoplasmonic colorimetry in microfluidics for antimicrobial susceptibility testing directly from specimens.
     Nat Nanotechnol. 2026;21:288-299.
     Abstract
     
     
250. RAMEY-COLLIER K, Russell R, Agrawal S, Hamm RF, et al
     Perspectives on Management of Recurrent UTIs Among Black Women.
     Urogynecology (Phila). 2026;32:240-249.
     Abstract
     
     
251. GALLARDO MOLINA P, Choi BI, Vanek M, Khan MH, et al
     SimUrine: a novel, fully defined artificial urinary medium for enhanced microbiological research of urinary bacteria.
     Appl Environ Microbiol. 2026;92:e0155925.
     Abstract
     
     
252. DODSON HE, Giaretta PR, McNulty KE, Aicher KM, et al
     Escherichia coli-associated renal malakoplakia in 2 dogs.
     J Vet Diagn Invest. 2026;38:342-345.
     Abstract
     
     
253. CARLSON J, Jhang D, Martin G, Roh D, et al
     Ureteral diameter ratio predicts breakthrough febrile UTI in children with primary vesicoureteral reflux.
     J Pediatr Urol. 2026;22:105626.
     Abstract
     
     
254. HOLDEN JG, Wallace S, Chang PW, Davis-Rodriguez S, et al
     Diagnostic evaluation and treatment of UTIs in children with neurogenic bladder.
     J Pediatr Urol. 2026;22:105602.
     Abstract
     
     
255. WEI CR, Basharat Z, Osama M, Mah K, et al
     An Overview of the Association of the Urinary Tract Microbiome with Various Diseases and Implications for Therapeutics.
     Mini Rev Med Chem. 2025;25:1420-1443.
     Abstract
     
     
256. AHENGAR Z, Pedersen CH, Falborg AZ, Plejdrup Hansen M, et al
     Clinical indications for antibiotic prescribing in Danish general practice.
     Scand J Prim Health Care. 2026;44:1-9.
     Abstract
     
     
257. SCHIPPERS E, van Uhm J, Wilmsen M, Tigchelaar A, et al
     The impact of catheter replacement in patients with catheter-associated urinary tract infection: study protocol paper for a multicentre, non-inferiority randomized controlled trial (REPLACE).
     BMC Infect Dis. 2026 Feb 27. doi: 10.1186/s12879-026-12890.
     Abstract
     
     
258. KREUTER J, Piglmann L, Priselac K, Martzy R, et al
     A rapid ionic liquid-based DNA extraction method for molecular diagnostics of urinary tract infections.
     Microbiol Spectr. 2026 Feb 27:e0319125. doi: 10.1128/spectrum.03191.
     Abstract
     
     
259. ZHENG X, Sun X, Du W, Sun S, et al
     Urine volatile organic compounds profiling via GC-IMS combined with machine learning: a powerful diagnostic and pathogen differentiation tool for urinary tract infections.
     Front Cell Infect Microbiol. 2026;16:1745468.
     Abstract
     
     
260. SEMET C, Gorgulu Y
     Beyond bacteremia: clinical phenotypes and determinants of mortality in hospitalized adults with community-acquired urinary tract infection.
     Front Med (Lausanne). 2026;13:1754663.
     Abstract
     
     
261. BALDISSERA GS, Doernberg SB, van Duin D, Hamasaki T, et al
     Development of a Kidney Transplant-Specific DOOR for Urinary Tract Infections Assessing the Impact of Carbapenem Resistance.
     Transpl Infect Dis. 2026 Feb 26:e70191. doi: 10.1111/tid.70191.
     Abstract
     
     
262. DOAN TN, Le TH, Chou LW
     Comparison of Urinary Tract Infection Rates Associated with Different Catheterization Methods Following Major Pelvic or Abdominal Surgery: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
     Life (Basel). 2026;16:280.
     Abstract
     
     
263. MISZEWSKA L, Miszewski K, Marczak B, Kucko G, et al
     From Awareness to Action: Women's Self-Care Strategies and Clinical Behaviors in Recurrent Urinary Tract Infections.
     Medicina (Kaunas). 2026;62:295.
     Abstract
     
     
264. AL-MUFARJI A, Rizvi M, Al-Kindi N, Al-Tamtami N, et al
     Mapping Escherichia coli in Women with Simple Urinary Tract Infections: Phenotypic ESBL/AmpC Screening and Whole-Genome Insights from Oman.
     Antibiotics (Basel). 2026;15:124.
     Abstract
     
     
265. PALUCK F, Kestenbom I, Test G, Carscadden E, et al
     Decreasing Invasive Urinary Tract Infection Screening in a Pediatric Emergency Department to Improve Quality of Care: Erratum.
     Pediatr Emerg Care. 2026;42:e61.
     Abstract
     
     
266. JOHN PP, Mike L, Mysorekar IU, Ruiz-Rosado JD, et al
     Urinary tract infections in children.
     Nat Rev Urol. 2026 Feb 26. doi: 10.1038/s41585-026-01130.
     Abstract
     
     
267. D'AMBROSIO F, Pappalardo C, Scardigno A, Medico MD, et al
     Silent Burden of Urinary Tract Infections in Intermittent Catheter Users with Neurological Disorders: A Scoping Review.
     Diseases. 2026;14:58.
     Abstract
     
     
268. SINGH RG, Nguyen E, Zhao Y, Zhang C, et al
     A randomized, triple-blind, placebo-controlled, parallel study of the efficacy of D-mannose for urinary tract infection symptoms in women.
     Curr Urol. 2026;20:44-52.
     Abstract
     
     
269. VATANPARAST Y
     An Unusual Cluster of Urinary Tract Infections, Including Salmonella spp., in an Iranian Ulcerative Colitis Cohort Treated With Vedolizumab: A Case Series and Comparative Analysis.
     JGH Open. 2026;10:e70355.
     Abstract
     
     
270. GROAH SL, Guemez AVA, Solman S
     Intravesical Therapeutics Among People With Spinal Cord Injury and Disease: Time for a Change.
     Top Spinal Cord Inj Rehabil. 2026;32:21-29.
     Abstract
     
     
271. MUKASHEMA H, Yadufashije C, Tuyishimire A, Imurinde Y, et al
     Profile of Biofilm Formation and Antimicrobial Susceptibility Patterns of Escherichia coli Isolated from Adult Patients Presenting with Urinary Tract Infections at Ruhengeri Level Two Teaching Hospital, Rwanda.
     Infect Drug Resist. 2026;19:559490.
     Abstract
     
     
272. WU W, Wu Q, Zhong W, Han L, et al
     Distribution and Drug-Resistance Analysis of Uropathogens in Urinary Tract Infections.
     Can J Infect Dis Med Microbiol. 2026;2026:1700474.
     Abstract
     
     
273. SHARMA S, Kapoor N, Kalra S
     Urinary Tract Infections and Obesity.
     J Pak Med Assoc. 2026;76:101-103.
     Abstract
     
     
274. ERDOGAN E, Yetisgen A, Dogan S, Sinanoglu MS, et al
     Multidrug-resistant uropathogens in pediatric urinary tract infections: a multicenter retrospective trend analysis (2020-2024).
     Naunyn Schmiedebergs Arch Pharmacol. 2026.
     Abstract
     
     
275. KOHLER KN, La Bella AA, Flores-Mireles AL
     Host Pathogen Interactions during Catheter-Associated Urinary Tract Infections.
     ACS Infect Dis. 2026 Feb 24. doi: 10.1021/acsinfecdis.5c01146.
     Abstract
     
     
276. PEREIRA DO NASCIMENTO LA, Pinto VBP, Gimenez LGS, Guimaraes T, et al
     Intravesical Gentamicin for Prevention of Recurrent Urinary Tract Infections in Patients With Neurogenic Lower Urinary Tract Dysfunction Performing Intermittent Catheterization: A Systematic Review.
     Neurourol Urodyn. 2026 Feb 23. doi: 10.1002/nau.70254.
     Abstract
     
     
277. GADHVI JG, Kenee PRM, Lutz KC, Khan F, et al
     Bladder wall-embedded bacteria associated with increased risk of recurrence after electrofulguration in women with antibiotic-recalcitrant urinary tract infection.
     JU Open Plus. 2025;3:e00077.
     Abstract
     
     
278. PAUDEL S, Curtis BE, Mobley HLT, Pearson MM, et al
     Cytolethal Distending Toxin Enhances Escherichia coli Urinary Tract Infection.
     bioRxiv [Preprint]. 2026 Feb 10:2026.02.09.704878.
     Abstract
     
     
279. SEPTIMUS EJ, Arya LA, Crapanzano-Sigafoos R, Dmochowski R, et al
     Prevention Strategies for All Hospital-Onset Urinary Tract Infections: Best Practice Consensus Recommendations.
     Open Forum Infect Dis. 2026;13:ofag060.
     Abstract
     
     
280. BEGUM NJ, Qasim M, Haq IU, Naveed H, et al
     Integrative Molecular and Structural Profiling of Escherichia coli Virulence Genes in Diabetes-Associated Infections.
     Curr Microbiol. 2026;83:200.
     Abstract
     
     
281. LINSUKE S, Madinga J, Roucher C, Miantezila MI, et al
     Liver and bladder morbidity in a Schistosoma mansoni and haematobium co-endemic area in the Democratic Republic of Congo.
     PLoS Negl Trop Dis. 2026;20:e0013999.
     Abstract
     
     
282. CASTANO MJ, Torres I, Villarruel KM, Navarro D, et al
     Flow cytometry parameters for predicting the successful identification of gram-negative bacilli in urine by MALDI-TOF MS.
     Diagn Microbiol Infect Dis. 2026;115:117303.
     Abstract
     
     
283. MAKKY S, Hussein AH, Mohamed AA, Essam K, et al
     Can phage-antibiotic combinations overcome uropathogenic Escherichia coli regrowth? evidence from in vitro and in vivo models.
     Virol J. 2026;23:50.
     Abstract
     
     
284. BABU R, Heera T, Sangeetha G
     Modified Top-Down Approach to Reduce Voiding Cystourethrograms: Diagnostic Accuracy of Late DMSA Scintigraphy and Renal Ultrasound for Predicting Vesicoureteral Reflux in Children > 2 Years. A Retrospective Audit.
     Indian Pediatr. 2026;63:191-195.
     Abstract
     
     
285. DE OLIVEIRA SS, de Moura CAB, Montenegro K, Vianna TCDC, et al
     Genomic insights into a multidrug-resistant uropathogenic Escherichia coli ST131-H30 strain associated with a fatal healthcare-associated infection.
     J Glob Antimicrob Resist. 2026;46:175-178.
     Abstract
     
     
286. ZHANG G, Wang L, Tang W, Huang Y, et al
     FANS-UAS under local anesthesia for urinary stones with high risk-postoperative urosepsis.
     Int J Surg. 2026;112:3553-3559.
     Abstract
     
     
287. CHOWERS M, Atias D, Gottesman B, Low M, et al
     Estimating antibiotic resistance following antibiotic treatment in outpatients: a retrospective study.
     Clin Microbiol Infect. 2026;32:446-452.
     Abstract
     
     
288. ZHANEL G, de Rossi P, Oliva C, Johansen TEB, et al
     Treatment of asymptomatic bacteriuria during pregnancy: A risk-factor-based approach.
     J Glob Antimicrob Resist. 2026;46:79-86.
     Abstract
     
     
289. AHMADI S, Foroohi F, Shirzadian M, Vosoughi AF, et al
     Distribution of acquired carbapenemase genes among uropathogenic Escherichia coli.
     Naunyn Schmiedebergs Arch Pharmacol. 2026;399:3477-3494.
     Abstract
     
     
290. NAGARAJU S, Masood PF, Goel HK, Makkar A, et al
     Comparison of augmented prophylaxis using intra-prostatic antibiotic injection with standard oral prophylaxis in preventing the infectious complications following trans-rectal ultrasound (TRUS)-guided prostatic biopsy: a randomized controlled study.
     Int Urol Nephrol. 2026;58:821-826.
     Abstract
     
     
291. IKEZOE E, Yajima S, Hirose K, Kataoka M, et al
     Concordance Between Ileal Stool Culture and Urinary Tract Infection Organisms After Robot-Assisted Radical Cystectomy With Ileal Conduit.
     Int J Urol. 2026;33:e70398.
     Abstract
     
     
292. YANG S, Lin Y, Chen Z
     Predictive Model Integrating Imaging and Inflammatory Biomarkers for Preoperative Urinary Tract Infection in Patients with Ureteral Calculi and Metabolic Syndrome.
     Arch Esp Urol. 2026;79:105-113.
     Abstract
     
     
293. VALA D, Pandya M, Chatterjee PB
     Advances in the Development of Antibiotic Drug Candidates for Urinary Tract Infection Therapy.
     Chem Asian J. 2026;21:e70659.
     Abstract
     
     
294. ZHANG J, Jiang YY, Zhu Y, Pan CY, et al
     Explainable machine learning for early detection of Escherichia coli urinary tract infections: integrating SHAP interpretation and bacterial epidemiology.
     Front Cell Infect Microbiol. 2026;16:1740707.
     Abstract
     
     
295. TANG Y, Zhang Y, Liu X, Chen G, et al
     Septic shock from urinary tract infection associated with sodium-glucose cotransporter 2 inhibitor in a high-risk patient with heart failure: A case report.
     J Int Med Res. 2026;54:3000605261421036.
     Abstract
     
     
296. KARA A, Massaro C, Boussoualim N, Elkolli M, et al
     Prevalence and Molecular Characterization of beta-Lactamase and Quinolone Resistance Genes in Imipenem-Non-Susceptible Uropathogenic Escherichia coli (UPEC) Isolates.
     Front Biosci (Landmark Ed). 2026;31:48045.
     Abstract
     
     
297. PETZOLDT S, Buschhaus C, Hecker M, Hauptmann A, et al
     High procalcitonin in Gram-negative urosepsis: indicator of immune modulation rather than poor outcome.
     World J Urol. 2026;44:207.
     Abstract
     
     
298. TALLAKSEN JM, Reinhart JM, Lopez-Villalobos N, Gal A, et al
     Subclinical bacteriuria and pyuria in companion animals without signs of lower urinary tract disease: prevalence and associations in a prospective cross-sectional study using multimodal analytics.
     J Vet Intern Med. 2026;40:aalaf092.
     Abstract
     
     
299. ONISHI K, Morioka H, Yamamoto M, Tsuchimoto D, et al
     Enhanced guideline-compliant antimicrobial prophylaxis based on preoperative urine culture pathogens reduces bloodstream infection and sepsis following ureteroscopic lithotripsy.
     J Infect Chemother. 2026;32:102924.
     Abstract
     
     
300. WIDHE E, Hambraeus M, Hedstrom E, Borjesson A, et al
     Low Risk for Urinary Tract Infection After Voiding Cystography in Children Without Dilated Vesikoureteral Reflux.
     Acta Paediatr. 2025 Dec 29. doi: 10.1111/apa.70437.
     Abstract
     
     
301. AL-JAWAHIRI Z, Basu M
     Bridging research and patient experience in chronic urinary tract infection.
     BJU Int. 2026 Feb 16. doi: 10.1111/bju.70185.
     Abstract
     
     
302. ANDERSEN K, Hjelmager JS, Andersen TE, Staerk K, et al
     Response to: Bridging research and patient experience in chronic urinary tract infection.
     BJU Int. 2026 Mar 4. doi: 10.1111/bju.70186.
     Abstract
     
     
303. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
     Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods.
     Clin Infect Dis. 2025 Dec 30:ciaf459. doi: 10.1093.
     Abstract
     
     
304. TANDE AJ, Stevens RW, Ilges D, Lahr BD, et al
     Cumulative Antibiotic Exposure Is Associated With Ceftriaxone Resistance Among Patients With Urinary Source Gram-negative Bloodstream Infection: A Retrospective Cohort Study.
     Clin Infect Dis. 2025;81:871-878.
     Abstract
     
     
305. SHEETS AJ, Dennison J, Pogue JM, Kaye KS, et al
     Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled analysis from two pivotal Phase 3 studies.
     Clin Infect Dis. 2026 Jan 6:ciaf722. doi: 10.1093.
     Abstract
     
     
306. CANTON R, Lim AN, Cortes V, Diaz-Reganon J, et al
     Uncomplicated Urinary Tract Infections: From an Invisible Impact to a Visible Change in Complex Care.
     Clin Infect Dis. 2026 Feb 25:ciaf705. doi: 10.1093.
     Abstract
     
     
307. PRADERE B, Schuit M, Guerrero-Ramos F, Shariat SF, et al
     Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels.
     Curr Opin Urol. 2025 Oct 8. doi: 10.1097/MOU.0000000000001350.
     Abstract
     
     
308. MASZKOWSKA J, Denkis A, Castanheira M, Sader HS, et al
     In vitro activity of furazidin and comparator agents against bacterial isolates from urinary tract infections.
     Eur J Clin Microbiol Infect Dis. 2026 Feb 2. doi: 10.1007/s10096-026-05418.
     Abstract
     
     
309. KUNWAR D, Zahavi I, Olchowski J, Dallasheh H, et al
     Antibiotic class comparisons for the treatment of pyelonephritis and complicated urinary tract infections: a systematic review and meta-analysis.
     Int J Antimicrob Agents. 2025 Dec 22:107696.
     Abstract
     
     
310. PIMENTA-DE-SOUZA P, Ramos-Silva A, Sandes V, Portella P, et al
     Ceftazidime/avibactam and ceftolozane/tazobactam for severe paediatric infections: A systematic review, meta-analysis, and evidence map.
     Int J Antimicrob Agents. 2026;67:107710.
     Abstract
     
     
311. LIAO J, Li C, Liu J, Wu W, et al
     Enhancing meropenem therapy in critical care: A retrospective study of PK/PD target attainment and therapeutic drug monitoring.
     Int J Antimicrob Agents. 2026;67:107697.
     Abstract
     
     
312. MANTZOURANI E, Ahmed H, Evans A, Macdonald S, et al
     A national pilot community pharmacy-led urinary tract infection service: clinical and patient-reported outcomes from 9077 consultations.
     J Antimicrob Chemother. 2025 Dec 24:dkaf466. doi: 10.1093.
     Abstract
     
     
313. ZHONG Y, Hope W, Buchan I, Velluva A, et al
     Machine learning for personalized antimicrobial susceptibility breakpoints.
     J Antimicrob Chemother. 2026;81:dkaf419.
     Abstract
     
     
314. IBRAHIM T, Burhan M, Naveed MA, Ali A, et al
     Safety and efficacy of gepotidacin in urinary tract infection: a GRADE-assessed systematic review and meta-analysis.
     J Antimicrob Chemother. 2026;81:dkaf469.
     Abstract
     
     
315. LESHIN-CARMEL D, Kariv L, Mor N, Neeman O, et al
     The effect of intrauterine exposure to aminoglycosides on neonatal hearing.
     J Antimicrob Chemother. 2026;81:dkaf483.
     Abstract
     
     
316. KUIL S, Bavalia R, Boyd A, de Jong M, et al
     Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study.
     J Antimicrob Chemother. 2025 Dec 17:dkaf451. doi: 10.1093.
     Abstract
     
     
317. LAN S, Wang H, Huang J, Li H, et al
     Implementing multimodal nursing strategies to reduce catheter-associated urinary tract infections in adult inpatients: A scoping review.
     J Hosp Infect. 2026 Jan 20:S0195-6701(26)00010.
     Abstract
     
     
318. MUKEREBE C, Cordeiro AA, Aristide C, Colombe S, et al
     Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota.
     J Infect Dis. 2025 Aug 22:jiaf447. doi: 10.1093.
     Abstract
     
     
319. FORSTER CS, Davis-Rodriguez S, Curry C, Tepe K, et al
     Diagnostic Accuracy of Urine Microbial Diversity and Urine NGAL for the Diagnosis of Urinary Tract Infections in Children with Spina Bifida.
     J Pediatr. 2026 Feb 18:115043. doi: 10.1016/j.jpeds.2026.115043.
     Abstract
     
     
320. SHUKLA AR, Srinivasan AK, Mittal S, Abdulfattah S, et al
     Reply: A Risk Stratification Model to Predict Febrile Urinary Tract Infection After Cessation of Continuous Antibiotic Prophylaxis in Children With Known Vesicoureteral Reflux.
     J Urol. 2025 Dec 31:101097JU0000000000004908. doi: 10.1097/JU.0000000000004908.
     Abstract
     
     
321. CORONA LE
     Letter: A Risk Stratification Model to Predict Febrile Urinary Tract Infection After Cessation of Continuous Antibiotic Prophylaxis in Children With Known Vesicoureteral Reflux.
     J Urol. 2025 Dec 23:101097JU0000000000004894. doi: 10.1097/JU.0000000000004894.
     Abstract
     
     
322. KHONDKER A, Rickard M, Maher S, Chua M, et al
     Ureteral dilation is a clinically significant risk factor for urinary tract infections in children with prenatal hydronephrosis: a call to revisit practice guidelines.
     J Urol. 2026 Jan 30:101097JU0000000000004966. doi: 10.1097/JU.0000000000004966.
     Abstract
     
     
323. HAJAJ C, Alkoby S, Ashkenazi S, Cohen AH, et al
     Machine Learning Tools for Predicting Pediatric Urinary Tract Infections Caused by ESBL-producing Bacteria.
     Pediatr Infect Dis J. 2026 Feb 12. doi: 10.1097/INF.0000000000005179.
     Abstract
     
     
324. TZVI-BEHR S, Frishberg Y, Cytter-Kuint R, Chertin B, et al
     Emphysematous pyelonephritis and infection-related calculi.
     Pediatr Nephrol. 2026;41:361-363.
     Abstract
     
     
325. KERN NG
     Editorial Comment on "Phimosis Treatment and Risk of Recurrent Urinary Tract Infection in Infant Males: A Systematic Review".
     Urology. 2026 Jan 8:S0090-4295(26)00006-3. doi: 10.1016/j.urology.2025.
     Abstract
     
     
326. ZIMMERN P, Kusin S, Fan E, Christie AL, et al
     Urinary pH, methenamine, and formaldehyde levels in the management of post-menopausal women with recurrent urinary tract infections: a one-year prospective pilot study with extended follow-up.
     Urology. 2026 Jan 19:S0090-4295(26)00023-3. doi: 10.1016/j.urology.2026.
     Abstract
     
     
327. WESTERHOUT SF, Rynja SP, van Steenbergen JPZ, Mertens LS, et al
     Antibiotic Prophylaxis Is Not Required Before MRI-Guided Transperineal Prostate Biopsy.
     Urology. 2026;207:166-171.
     Abstract
     
     
328. NEWLANDS AF, Tidmarsh LV, Kramer M, Bradbury M, et al
     The Recurrent Urinary Tract Infection Symptom Scale (RUTISS): Responsiveness to antibiotic treatment and the minimal clinically important difference.
     Urology. 2026 Jan 22:S0090-4295(26)00035-X. doi: 10.1016/j.urology.2026.
     Abstract
     
     
329. PFAIL J, Passarelli R, Concodora C, Ahmed H, et al
     Contemporary Analysis of 30-Day UTI Rates Post-ureteral Reimplantation in VUR Patients: Evaluating the Role of Discharge Antibiotics.
     Urology. 2026;208:142-145.
     Abstract
     
     
330. BAER BR, Matheny MV, Raman JD
     Timeline for Resolution of Hematuria Following Treatment of Urinary Tract Infection and Implications for Confirmatory Testing.
     Urology. 2026;208:1-6.
     Abstract
     
     
331. NGUYEN C, Broadwell NH, Paz A, Applewhite J, et al
     Predictive Factors of Symptomatic UTIs in a Large Cohort of Pediatric Patients Undergoing Voiding Cystourethrogram.
     Urology. 2026;208:124-129.
     Abstract
     
     
332. KRAUSE A, Zane GK, Rivas-Nieto AC, Mulugeta A, et al
     Assessing the relationship between menstrual products and reproductive and urogenital tract infections (RUTIs): A systematic review evaluating the evidence and recommendations for future research.
     PLoS One. 2025;20:e0332006.
     Abstract
     
     
333. ASHONG Y, Aboagye FT, Owusu-Frimpong I, Nyarko S, et al
     Prevalence of Schistosoma bovis and Schistosoma haematobium hybrids in endemic communities in Ghana.
     PLoS One. 2026;21:e0339722.
     Abstract
     
     
334. FOX AP, Aguirre Guemez AV, Skipwith C, Cavin C, et al
     Urine resazurin reduction ratio as a biomarker of urinary tract infection in people with neurogenic bladder: A first in human study.
     PLoS One. 2026;21:e0341599.
     Abstract
     
     
335. MOUANGA-NDZIME Y, Bisseye C, Dikoumba AC, Ekore DO, et al
     High burden and genetic diversity of beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing community-acquired urinary tract infections in Southeastern Gabon.
     PLoS One. 2026;21:e0343632.
     Abstract